These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13544657)

  • 1. Effect of fungistatic agents on corneal infections with Candida albicans.
    MONTANA JA; SERY TW
    AMA Arch Ophthalmol; 1958 Jul; 60(1):1-6. PubMed ID: 13544657
    [No Abstract]   [Full Text] [Related]  

  • 2. A method for evaluation of antifungal drugs against enteric Candida albicans in mice.
    LINDH HF
    Antibiot Chemother (Northfield); 1959 Apr; 9(4):226-31. PubMed ID: 24545206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental research on the relation between antibiotics and infections caused by Candidae. II. Action of antimycotics on experimental infection by Candida albicans in the mouse].
    GIUNCHI G; ORTONA L; SORICE F; VISCO G
    Clin Ter; 1959 Nov; 17():487-98. PubMed ID: 13828266
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man.
    HALDE C; NEWCOMER VD; WRIGHT ET; STERNBERG TH
    J Invest Dermatol; 1957 Mar; 28(3):217-31; discussion, 231-2. PubMed ID: 13429161
    [No Abstract]   [Full Text] [Related]  

  • 5. [On a case of keratomycosis of the human cornea caused by Candida albicans].
    GRAF K
    Klin Monbl Augenheilkd; 1963; 142():578-81. PubMed ID: 13949746
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
    Onyewu C; Afshari NA; Heitman J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3963-5. PubMed ID: 16923949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFFECTS OF ANTIBIOTICS ON EXPERIMENTAL CANDIDA CORNEAL INFECTIONS.
    VANWINKLE MG; RHEINS MS; SUIE T
    Am J Ophthalmol; 1964 Jan; 57():84-7. PubMed ID: 14106907
    [No Abstract]   [Full Text] [Related]  

  • 8. Moniliasis; a review and a report of the first case demonstrating the Candida albicans in the cornea.
    MENDELBLATT DL
    Am J Ophthalmol; 1953 Mar; 36(3):379-85. PubMed ID: 13030643
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
    Spierer O; Dugar J; Miller D; OʼBrien TP
    Cornea; 2015 May; 34(5):576-9. PubMed ID: 25826327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of K-582, a new antifungal agent, on experimental Candida keratitis.
    Ohno S; Fuerst DJ; Okumoto M; Grabner G; Smolin G
    Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1626-9. PubMed ID: 6360948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
    Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
    Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal anesthetic abuse and Candida keratitis.
    Chern KC; Meisler DM; Wilhelmus KR; Jones DB; Stern GA; Lowder CY
    Ophthalmology; 1996 Jan; 103(1):37-40. PubMed ID: 8628558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental acute visceral Candida infection in mice and its use in the investigation of therapeutic effectiveness of anti-fungal antibiotics and other chemical substances].
    FOMINA IP; STEPANISHCHEVA ZG
    Antibiotiki (Mosc); 1957; 2(6):34-8. PubMed ID: 24544740
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimaricin, a new fungistatic.
    de ROOY A
    Ophthalmologica; 1961 Jun; 141():489. PubMed ID: 13743198
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
    Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitinase 3-Like 1 Promotes Candida albicans Killing and Preserves Corneal Structure and Function by Controlling Host Antifungal Responses.
    Gao N; Yu FS
    Infect Immun; 2015 Oct; 83(10):4154-64. PubMed ID: 26238714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
    Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K
    Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISG15 in Host Defense Against Candida albicans Infection in a Mouse Model of Fungal Keratitis.
    Dong C; Gao N; Ross BX; Yu FX
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2948-2958. PubMed ID: 28599020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium.
    Layer N; Cevallos V; Maxwell AJ; Hoover C; Keenan JD; Jeng BH
    JAMA Ophthalmol; 2014 Jul; 132(7):832-7. PubMed ID: 24789459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.